{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:04:42Z","timestamp":1778259882621,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bayer"},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Corona Foundation, German Innovation Fonds"},{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Stroke has a deleterious impact on quality of life. However, it is less well known if stroke lesions in different brain regions are associated with reduced quality of life (QoL). We therefore investigated this association by multivariate lesion-symptom mapping. We analyzed magnetic resonance imaging and clinical data from the WAKE-UP trial. European Quality of Life 5 Dimensions (EQ-5D) 3 level questionnaires were completed 90\u00a0days after stroke. Lesion symptom mapping was performed using a multivariate machine learning algorithm (support vector regression) based on stroke lesions 22\u201336\u00a0h after stroke. Brain regions with significant associations were explored in reference to white matter tracts. Of 503 randomized patients, 329 were included in the analysis (mean age 65.4\u00a0years, SD 11.5; median NIHSS\u2009=\u20096, IQR 4\u20139; median EQ-5D score 90\u00a0days after stroke 1, IQR 0\u20134, median lesion volume 3.3\u00a0ml, IQR 1.1\u201316.9\u00a0ml). After controlling for lesion volume, significant associations between lesions and EQ-5D score were detected for the right putamen, and internal capsules of both hemispheres. Multivariate lesion inference analysis revealed an association between injuries of the cortico-spinal tracts with worse self-reported quality of life 90\u00a0days after stroke in comparably small stroke lesions, extending previous reports of the association of striato-capsular lesions with worse functional outcome. Our findings are of value to identify patients at risk of impaired QoL after stroke.<\/jats:p>","DOI":"10.1038\/s41598-021-92865-x","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T10:07:24Z","timestamp":1624961244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Influence of stroke infarct location on quality of life assessed in a multivariate lesion-symptom mapping study"],"prefix":"10.1038","volume":"11","author":[{"given":"Alina","family":"K\u00f6nigsberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"DeMarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eckhard","family":"Schlemm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Ebinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae-Hee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Endres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen B.","family":"Fiebach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Fiehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Galinovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Thijs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Lemmens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith W.","family":"Muir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Nighoghossian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Pedraza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus Z.","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gerloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6tz","family":"Thomalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"92865_CR1","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J. & van Gijn, J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19, 604\u2013607 (1988).","journal-title":"Stroke"},{"key":"92865_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S1474-4422(06)70495-1","volume":"5","author":"SE Kasner","year":"2006","unstructured":"Kasner, S. E. Clinical interpretation and use of stroke scales. Lancet Neurol. 5, 603\u2013612 (2006).","journal-title":"Lancet Neurol."},{"key":"92865_CR3","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/STROKEAHA.117.018912","volume":"49","author":"M Reeves","year":"2018","unstructured":"Reeves, M. et al. Patient-reported outcome measures (PROMs) for acute stroke: Rationale, methods and future directions. Stroke 49, 1549\u20131556 (2018).","journal-title":"Stroke"},{"key":"92865_CR4","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMp1011024","volume":"363","author":"ME Porter","year":"2010","unstructured":"Porter, M. E. What is value in health care?. N. Engl. J. Med. 363, 2477\u20132481 (2010).","journal-title":"N. Engl. J. Med."},{"key":"92865_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin, R. & De Charro, F. EQ-5D: A measure of health status from the EuroQol Group. Ann. Med. 33, 337\u2013343 (2001).","journal-title":"Ann. Med."},{"key":"92865_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/01.STR.0000251792.76080.45","volume":"38","author":"NM Menezes","year":"2007","unstructured":"Menezes, N. M. et al. The real estate factor: Quantifying the impact of infarct location on stroke severity. Stroke 38, 194\u2013197 (2007).","journal-title":"Stroke"},{"key":"92865_CR7","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1161\/STROKEAHA.114.005152","volume":"45","author":"B Cheng","year":"2014","unstructured":"Cheng, B. et al. Influence of stroke infarct location on functional outcome measured by the modified rankin scale. Stroke 45, 1695\u20131702 (2014).","journal-title":"Stroke"},{"key":"92865_CR8","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1093\/brain\/awu164","volume":"137","author":"YH Mah","year":"2014","unstructured":"Mah, Y. H., Husain, M., Rees, G. & Nachev, P. Human brain lesion-deficit inference remapped. Brain 137, 2522\u20132531 (2014).","journal-title":"Brain"},{"key":"92865_CR9","first-page":"2461","volume":"21","author":"A DeMarco","year":"2006","unstructured":"DeMarco, A. & Turkeltaub, P. A multivariate lesion symptom mapping toolbox and examination of lesion-volume biases and correction methods in lesion-symptom mapping. Brain 21, 2461\u20132467 (2006).","journal-title":"Brain"},{"key":"92865_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1162\/nol_a_00015","volume":"1","author":"AS Mandal","year":"2020","unstructured":"Mandal, A. S. et al. Brain structures and cognitive abilities important for the self-monitoring of speech errors. Neurobiol. Lang. 1, 1\u201352 (2020).","journal-title":"Neurobiol. Lang."},{"issue":"3","key":"92865_CR11","first-page":"1","volume":"7","author":"C Foulon","year":"2018","unstructured":"Foulon, C. et al. Advanced lesion symptom mapping analyses and implementation as BCBtoolkit. Gigascience. 7(3), 1\u201317 (2018).","journal-title":"bioRxiv."},{"key":"92865_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1161\/01.STR.26.3.402","volume":"26","author":"RJ de Haan","year":"1995","unstructured":"de Haan, R. J., Limburg, M., Van der Meulen, J. H., Jacobs, H. M. & Aaronson, N. K. Quality of life after stroke: Impact of stroke type and lesion location. Stroke 26, 402\u2013408 (1995).","journal-title":"Stroke"},{"key":"92865_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/1747493018783760","volume":"13","author":"C Lin","year":"2018","unstructured":"Lin, C. et al. Infarct location is associated with quality of life after mild ischemic stroke. Int. J. Stroke. 13, 824\u2013831 (2018).","journal-title":"Int. J. Stroke."},{"key":"92865_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12955-018-1043-3","volume":"16","author":"YS Yeoh","year":"2018","unstructured":"Yeoh, Y. S. et al. Can acute clinical outcomes predict health-related quality of life after stroke: A one-year prospective study of stroke survivors. Health Qual. Life Outcomes. 16, 1\u20139 (2018).","journal-title":"Health Qual. Life Outcomes."},{"key":"92865_CR15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.59566\/IJBS.2012.8183","volume":"8","author":"SA Abubakar","year":"2012","unstructured":"Abubakar, S. A. & Isezuo, S. A. Health related quality of life of stroke survivors: Experience of a stroke unit. Int. J. Biomed. Sci. 8, 183\u2013187 (2012).","journal-title":"Int. J. Biomed. Sci."},{"key":"92865_CR16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000452634","volume":"6","author":"S Rangaraju","year":"2017","unstructured":"Rangaraju, S., Haussen, D., Nogueira, R. G., Nahab, F. & Frankel, M. Comparison of 3-month stroke disability and quality of life across modified rankin scale categories. Interv. Neurol. 6, 36\u201341 (2017).","journal-title":"Interv. Neurol."},{"key":"92865_CR17","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1212\/01.wnl.0000260967.77422.97","volume":"68","author":"GJ Hankey","year":"2007","unstructured":"Hankey, G. J. et al. Rate, degree, and predictors of recovery from disability following ischemic stroke. Neurology 68, 1583\u20131587 (2007).","journal-title":"Neurology"},{"key":"92865_CR18","first-page":"216","volume":"3","author":"JA Opara","year":"2010","unstructured":"Opara, J. A. & Jaracz, K. Quality of life of post-stroke patients and their caregivers. J. Med. Life. 3, 216\u2013220 (2010).","journal-title":"J. Med. Life."},{"key":"92865_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000200461","volume":"27","author":"FJ Carod-Artal","year":"2009","unstructured":"Carod-Artal, F. J. & Egido, J. A. Quality of life after stroke: The importance of a good recovery. Cerebrovasc. Dis. 27, 204\u2013214 (2009).","journal-title":"Cerebrovasc. Dis."},{"key":"92865_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-018-1198-x","volume":"18","author":"P Thingstad","year":"2018","unstructured":"Thingstad, P. et al. The Norwegian Cognitive impairment after stroke study (Nor-COAST): Study protocol of a multicentre, prospective cohort study. BMC Neurol. 18, 1\u201310 (2018).","journal-title":"BMC Neurol."},{"key":"92865_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1804355","volume":"379","author":"G Thomalla","year":"2018","unstructured":"Thomalla, G. et al. MRI-guided thrombolysis for stroke with unknown time of onset. N. Engl. J. Med. 379, 611\u2013622 (2018).","journal-title":"N. Engl. J. Med."},{"key":"92865_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/STROKEAHA.119.027390","volume":"51","author":"B Cheng","year":"2020","unstructured":"Cheng, B. et al. Quantitative signal intensity in fluid-attenuated inversion recovery and treatment effect in the WAKE-UP trial. Stroke 51, 209\u2013215 (2020).","journal-title":"Stroke"},{"key":"92865_CR23","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1098\/rstb.2001.0915","volume":"356","author":"J Mazziotta","year":"2001","unstructured":"Mazziotta, J. et al. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos. Trans. R. Soc. B 356, 1293\u20131322 (2001).","journal-title":"Philos. Trans. R. Soc. B"},{"key":"92865_CR24","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.1002\/hbm.22590","volume":"35","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y., Kimberg, D. Y., Coslett, H. B., Schwartz, M. F. & Wang, Z. Multivariate lesion-symptom mapping using support vector regression. Hum. Brain Mapp. 35, 5861\u20135876 (2014).","journal-title":"Hum. Brain Mapp."},{"key":"92865_CR25","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1002\/hbm.24289","volume":"39","author":"AT DeMarco","year":"2018","unstructured":"DeMarco, A. T. & Turkeltaub, P. E. A multivariate lesion symptom mapping toolbox and examination of lesion-volume biases and correction methods in lesion-symptom mapping. Hum. Brain Mapp. 39, 4169\u20134182 (2018).","journal-title":"Hum. Brain Mapp."},{"key":"92865_CR26","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan, R. S. et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968\u2013980 (2006).","journal-title":"Neuroimage"},{"key":"92865_CR27","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.neuroimage.2004.12.034","volume":"25","author":"SB Eickhoff","year":"2005","unstructured":"Eickhoff, S. B. et al. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25, 1325\u20131335 (2005).","journal-title":"Neuroimage"},{"key":"92865_CR28","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00429-015-1001-3","volume":"221","author":"K Rojkova","year":"2016","unstructured":"Rojkova, K. et al. Atlasing the frontal lobe connections and their variability due to age and education: A spherical deconvolution tractography study. Brain Struct Funct 221, 1751\u20131766 (2016).","journal-title":"Brain Struct Funct"},{"key":"92865_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/cercor\/bhs351","volume":"24","author":"MT De Schotten","year":"2014","unstructured":"De Schotten, M. T. et al. Damage to white matter pathways in subacute and chronic spatial neglect: A group study and 2 single-case studies with complete virtual \u201cin vivo\u201d tractography dissection. Cereb. Cortex. 24, 691\u2013706 (2014).","journal-title":"Cereb. Cortex."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92865-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92865-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92865-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T12:09:57Z","timestamp":1699186197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92865-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92865"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92865-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"27 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AK reports grants from European Union 7th Framework Program during the conduct of the study. ADM has nothing to disclose. CM has nothing to disclose. AW has nothing to disclose. ES has nothing to disclose. ME reports grants from European Union 7th Framework Program during the conduct of the study. THC has nothing to disclose. MEn reports grants from European Union 7th Framework Program during the conduct of the study, grants from Bayer and fees paid to the Charit\u00e9 from Bayer, Boehringer Ingelheim, BMS\/Pfizer, Daiichi Sankyo, Amgen, GlaxoSmithKlineGSK, Sanofi, Covidien, Novartis, all outside the submitted work. JBF reports grants from European Union 7th Framework Program during the conduct of the study and personal fees from Bioclinica, BMS, Biogen, Artemida, Cerevast, Guerbet, EISAI and Nicolab outside the submitted work. JF has nothing to disclose. IG reports grants from European Union 7th Framework Program during the conduct of the study. JP has nothing to disclose. VT reports grants from European Union 7th Framework Program and personal fees and non-financial support from Boehringer Ingelheim, Pfizer\/BMS, Bayer, Sygnis, Amgen and Allergan outside the submitted work. RL reports no personal fees, but institutional support for consultancy and speaker fees from Bayer, Boehringer-Ingelheim, Genentech, Ischemaview, Medtronic and Occlutech outside the submitted work. KWM reports grants from European Union 7th Framework Program during the conduct of the study, personal fees and non-financial support from Boehringer Ingelheim outside the submitted work, personal fees from Boehringer Ingelheim, Bayer, Daiichi Sankyo and ReNeuron outside the submitted work. NN has nothing to disclose. SP reports grants from European Union 7th Framework Program during the conduct of the study. CZS reports grants from Novo Nordisk Foundation and personal fees from Bayer outside the submitted work. CG reports grants from European Union 7th Framework Program during the conduct of the study, personal fees from AMGEN, Bayer Vital, BMS, Boehringer Ingelheim, Sanofi Aventis, Abbott, and Prediction Biosciences outside the submitted work. GT reports grants from European Union 7th Framework Program during the conduct of the study, personal fees from Acandis, Boehringer Ingelheim, BMS\/Pfizer, Stryker, Daiichi Sankyo, grants and personal fees from Bayer, grants from Corona Foundation, German Innovation Fonds and Else Kroener Fresenius Foundation outside the submitted work. BC reports grants from European Union 7th Framework Program during the conduct of the study and personal fees from Bayer Vital and Abbott, all outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13490"}}